Prostaglandin Tri-mix 8.33:22.5:0.833 Vial recalls
The FDA has published 1 recall involving Prostaglandin Tri-mix 8.33:22.5:0.833 Vial since 2019. The latest was reported on 24 Apr 2019. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 24 Apr 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why prostaglandin tri-mix 8.33:22.5:0.833 vial is recalled
Companies
By year
All prostaglandin tri-mix 8.33:22.5:0.833 vial recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Prostaglandin Tri-Mix 8.33:22.5:0.833 Injection Vial recalled | Anderson Compounding Pharmacy | Sterility | Nationwide |
Should you stop taking Prostaglandin Tri-mix 8.33:22.5:0.833 Vial?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.